Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00937443 · ClinicalTrials.gov registry record

Effectiveness of a Walking Program Modulating Cardioreparative Factors in Heart Failure

A clinical trial, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
9
Enrollment target

NCT00937443 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 9 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00937443 has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
9 participants
Enrollment target

Study Summary

The incidence of heart failure grows as the population continues to age. Heart failure incidence approaches 10 per 1,000 persons after the age of 65. Although pharmacotherapy improves the treatment of heart failure it remains insufficient in preventing the progression of this debilitating disease. Cell based therapy has gained great strides over the last decade, launching cellular therapy into the mix of artillery for the treatment of chronic heart failure and coronary disease. While early pre-clinical work demonstrates that stem cell based therapy improves heart failure the exact mechanism in which these endothelial progenitor cells (EPC's) are recruited from the bone marrow, proliferate under the mediation of growth factors, and migrate to the injured tissues endogenously still remains obscured. Therefore in order for clinicians and scientist to impact heart failure treatment, a greater understanding of the physiological changes in EPC's and other modulators of cardioreparative process need further investigation.

Interventions

  • OTHER Physical Fitness
  • BIOLOGICAL Walking Exercise Group

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2009-07
Est. Completion 2014-01

What the Registry Record Tells You About NCT00937443

The ClinicalTrials.gov registry entry for NCT00937443 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Physical Fitness is the first listed.

NCT00937443 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00937443 about?

NCT00937443 is a clinical study titled "Effectiveness of a Walking Program Modulating Cardioreparative Factors in Heart Failure". The incidence of heart failure grows as the population continues to age. Heart failure incidence approaches 10 per 1,000 persons after the age of 65. Although pharmacotherapy improves the treatment of heart failure it remains insufficient in preventing the progression of this debilitating disease. C...

What is the current status of trial NCT00937443?

This trial is currently completed. The enrollment target is 9 participants. The study started on 2009-07. Estimated completion is 2014-01.

What interventions are being tested in trial NCT00937443?

The interventions under investigation include: Physical Fitness (OTHER), Walking Exercise Group (BIOLOGICAL).

Who is sponsoring clinical trial NCT00937443?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.